Philadelphia chromosome-positive B-lymphoblastic lymphoma successfully treated with chemotherapy regimen containing imatinib: A rare case report and literature review

RATIONALE: B-lymphoblastic lymphoma (B-LBL) with BCR/ABL mutation (Ph+ B-LBL) is a rare type of cancer in both childhood and adults. Its clinical manifestations are similar to those of other types lymphoma. However, the targeted therapy can substantially improve the outcome of Ph+ B-LBL. PATIENT CON...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Xiaoning, Cao, Weijie, Zhang, Suping, Li, Li, Li, Yingmei, Jiang, Zhongxing, Wan, Dingming, Yu, Jifeng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2021
Materias:
4800
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8202563/
https://www.ncbi.nlm.nih.gov/pubmed/34115047
http://dx.doi.org/10.1097/MD.0000000000026323

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8202563/
https://www.ncbi.nlm.nih.gov/pubmed/34115047
http://dx.doi.org/10.1097/MD.0000000000026323

Ejemplares similares